StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Horizon Carrier Screening Revenue [legacy through Q3 by Quarter

Horizon Carrier Screening (HCS) Revenue ($M) [legacy through Q3 2019] ($M)

Natera Horizon Carrier Screening Revenue [legacy through Q3: $26.2M in Q3 2019, up 11.0% from a year earlier. That is the highest of the 10 quarters on record here. No newer figure appears in the documents we track.

Latest, Q3 2019
26.2
Period ended Sep 30, 2019
Change on a year earlier
+11.0%
23.6 in Q3 2018
History
10 quarters
Since Q2 2017
Sources
6
Documents cited below

Where the Q3 2019 figure comes from

Source: Form 10-Q (2019-11-08) ↗

Reported in Form 10-K/10-Q Note — Disaggregated Product Revenue (2016–2019Q3).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedHorizon Carrier Screening (HCS) Revenue ($M) [legacy through Q3 2019] ($M)Year on yearSource
Q3 2019Sep 30, 201926.2+11.0%Form 10-Q (2019-11-08) ↗
Q2 2019Jun 30, 201924.3+13.4%Form 10-Q (2019-08-09) ↗
Q1 2019Mar 31, 201922.8+24.6%Form 10-Q (2019-05-10) ↗
Q4 2018Dec 31, 201823.9+48.1%Form 10-K (2019-03-15) ↗
Q3 2018Sep 30, 201823.6+31.6%Form 10-Q (2019-11-08) ↗
Q2 2018Jun 30, 201821.4+30.1%Form 10-Q (2019-08-09) ↗
Q1 2018Mar 31, 201818.3–Form 10-Q (2019-05-10) ↗
Q4 2017Dec 31, 201716.2–Form 10-K (2019-03-15) ↗
Q3 2017Sep 30, 201717.9–Form 10-Q (2018-11-09) ↗
Q2 2017Jun 30, 201716.5–Form 10-Q (2018-08-09) ↗

Cite this data

StockData. (2026). Natera Horizon Carrier Screening Revenue [legacy through Q3 ($M), quarterly Q2 2017–Q3 2019 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-legacy-horizon-hcs

See every metric in the Natera KPI table. Data updated Nov 2, 2026.